Midodrine Dosing Parameters for Orthostatic Hypotension
Midodrine should be individually tailored at a dose of 10 mg three times daily, with the first dose taken before arising and the last dose at least 4 hours before bedtime to avoid supine hypertension. 1
Dosing Recommendations
- Starting dose: 2.5-5 mg three times daily
- Target dose: Up to 10 mg three times daily
- Maximum daily dose: 30-40 mg (divided into 3-4 doses)
- Timing of doses:
- Dose titration: Increase by 2.5 mg increments weekly until desired response or maximum dose 3
Pharmacokinetic Parameters
- Onset of action: Within 1 hour
- Peak effect: 1-2 hours after administration
- Duration of action: 2-4 hours (with effects on standing blood pressure lasting up to 3-4 hours) 2, 4
- Half-life:
- Midodrine (prodrug): 25 minutes
- Desglymidodrine (active metabolite): 3-4 hours 2
Monitoring Parameters
Blood pressure response:
- Target: Increase in standing systolic BP by 15-30 mmHg at 1 hour post-dose 2
- Monitor both standing and supine blood pressure
Symptom improvement:
Supine hypertension:
- Monitor for supine systolic BP >180 mmHg
- Occurs in up to 25% of patients 6
- May require dose adjustment or timing modification
Precautions and Contraindications
Avoid in patients with:
- Severe cardiac disease
- Acute renal failure
- Urinary retention
- Pheochromocytoma
- Thyrotoxicosis
- Pre-existing sustained supine hypertension >180/110 mmHg 2
Use with caution in:
- Patients with prostatic hypertrophy
- Visual problems
- Hepatic impairment
Common Adverse Effects
- Piloerection (goosebumps)
- Pruritus (scalp tingling/itching)
- Paresthesias
- Urinary retention or urgency
- Supine hypertension
- Bradycardia
- Gastrointestinal symptoms 1, 2, 3
Treatment Algorithm
First-line approach: Non-pharmacological measures
If symptoms persist: Initiate midodrine therapy
If response inadequate: Consider combination therapy
If adverse effects occur:
- Reduce dose or adjust timing of administration
- Consider alternative agents
Remember that the therapeutic goal is to minimize postural symptoms rather than to restore normotension 1, 8, 9. Continue midodrine only in patients who report significant symptomatic improvement 2.